News
Life Sciences M&A Values Soar in 2011 May 14, 2012 | Press Release
Life Sciences M&A Activity Heats Up in April, says Burrill & Company May 01, 2012 | Press Release
Burrill & Company Leads $12.9 Million Series E Round In WhiteGlove Health April 16, 2012 | Press Release
See all News
Burrill & Company Leads $16.5 Million Round in WaveTec Vision to Commercialize Its Cataract Surgery Breakthrough
April 16, 2012
Government, Academics, and VCs Come Together to Fund Translational and Early-Stage Development
March 30, 2012
Burrill & Company Advises Aldagen, Inc. in Sale of its Next Generation Cell Therapy to Cytomedix, Inc.
February 21, 2012